MichaelHWeismanMD
Rheumatology • Los Angeles, CARheumatoid Arthritis & Related, Spondyloarthropathy
Professor, Medicine, UCLA School of Medicine
Are you Dr. Weisman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 83 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8700 Beverly Blvd.
Los Angeles, CA 90048Phone+1 310-423-2170Fax+1 310-423-6898- Is this information wrong?
Summary
- Dr. Michael Weisman, MD is a rheumatologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Cedars-Sinai Medical Center and is a Professor at UCLA School of Medicine.
Education & Training
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1969 - 1973- University of California (San Diego) Medical CenterInternship, Transitional Year, 1968 - 1969
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1968
Certifications & Licensure
CA State Medical License 1970 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis Start of enrollment: 2010 May 01
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis Start of enrollment: 2011 Jan 01
- One-Time DNA Study for Vasculitis Start of enrollment: 2010 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Preface.Michael H Weisman> ;Rheumatic Diseases Clinics of North America. 2024 Feb 1
- Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes ...Paras Karmacharya, Cynthia S Crowson, Ryan J Lennon, Dilli Poudel, John M Davis 3rd, Alexis Ogdie, Jean W Liew, Michael M Ward, Mariko Ishimori, Michael H Weisman, Mat...> ;Seminars in Arthritis and Rheumatism. 2024 Feb 1
- Emerging Concepts in Immune Dysregulation.Michael H Weisman> ;Rheumatic Diseases Clinics of North America. 2023 Nov 1
- Join now to see all
Press Mentions
Device Implants Need Better Labels, Advisers Tell FDANovember 15th, 2019
Modern Medical Terms Are Still Named After Nazi Doctors. Can We Change It?November 15th, 2012
Promising Drug Proves Ineffective as Treatment for Hearing LossOctober 8th, 2003- Join now to see all
Grant Support
- Inflammatory Markers In The Stool And Serum Of Patients With Ankylosing SpondyliNational Center For Research Resources2010
- Project 3: Defining The Spectrum Of Spondyloarthritis In Family MembersNational Center For Research Resources2009–2010
- Genetic Susceptibility To Lipid-Lowering Drug-Induced MyopathiesNational Center For Research Resources2009–2010
- A Comprehensive Model Of Severity In Outcomes In Ankylosing SpondylitisNational Center For Research Resources2008–2010
- Rheumatoid Arthritis Associated Autoimmunity In High Risk PopulationsNational Center For Research Resources2006–2010
- Clinical Trial: Behavioral Treatments For Rheumatoid ArthritisNational Center For Research Resources2008–2009
- Genetic Determinants Of Ankylosing Spondylitis Severity: Cross Sectional StudyNational Center For Research Resources2004–2008
- Behavioral Treatments For Rheumatoid ArthritisNational Center For Research Resources2005–2007
- Efficacy Of CAM Intervention In Rheumatoid ArthritisNational Center For Research Resources2006
- Rheumatoid Arthritis Associated Autoimmunity In High Risk Populations:StudNational Center For Research Resources2005
- Family Studies Of Microsatellite Gene Markers In Patients With AnkylosingNational Center For Research Resources2004–2005
- Genetic Determinants Of Ankylosing Spondylitis SeverityNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2005
- Leflunomide VS Placebo For Active Rheumatoid ArthritisNational Center For Research Resources2000–2002
- Ro32 3555 Trocade In Structural Joint Damage In Rheumatoid ArthritisNational Center For Research Resources1999–2002
- Hydroxychloroquine Or Acetaminophen In Nodal ArthritisNational Center For Research Resources1999–2002
- LJP 394 Administered To Patients With Systemic Lupus ErythematosusNational Center For Research Resources1998–2002
- Anti TNF Chimeric Monoclonal Antibody In Acute Rheumatoid ArthritisNational Center For Research Resources1998–2002
- Family Studies Of Microsatellite Gene Markers In Ankylosing SpondylitisNational Center For Research Resources2000
- Recombinant Human Interleukin Eleven In Rheumatoid ArthritisNational Center For Research Resources1999
- Induction Course &Maintenance Cycle Of Ag4263 In Rheumatoid ArthritisNational Center For Research Resources1999
- Anti TNF Antibody D2e7 IV Injection In Rheumatoid ArthritisNational Center For Research Resources1999
- Sc56835 For Treatment Of Osteoarthritis And Rheumatoid ArthritisNational Center For Research Resources1998–1999
- Oral Colloral In Patients With Rheumatoid ArthritisNational Center For Research Resources1998–1999
- Long Term Observation Of Patients With Early Rheumatoid ArthritisNational Center For Research Resources1998–1999
- Stnfr551gg And Methotrexate In Treating Patients With ArthritisNational Center For Research Resources1997–1999
- Sb210396 In Treatment Of Rheumatoid ArthritisNational Center For Research Resources1996–1999
- Psychosocial Aspects Of SclerodermaNational Center For Research Resources1996–1999
- DHEA For Treatment Of Systemic Lupus ErythematosusNational Center For Research Resources1996–1999
- Study Of Oral Ccii In Treatment Of Active Rheumatoid ArthritisNational Center For Research Resources1995–1999
- Recombinant Human Interleukin Eleven In Active Rheumatoid ArthritisNational Center For Research Resources1998
- Osteoarthritis Safety And Pilot Efficacy Study Of L 748,731National Center For Research Resources1996–1997
- D-Penicillamine In Systemic SclerosisNational Center For Research Resources1995–1997
- 2cda In The Treatment Of Psoriatic Arthritis And PsoriasisNational Center For Research Resources1995–1997
- Pharmacodynamic Effective Of Single Dose Of Ljp394 In SLENational Center For Research Resources1996
- Ljp394 In Patients With Systemic Lupus ErythematosusNational Center For Research Resources1996
- Three Loading Doses Of Hydroxychloroquine In Rheumatoid ArthritisNational Center For Research Resources1995–1996
- Three Dosage Regimens Of Stnfr-Igg In Rheumatoid ArthritisNational Center For Research Resources1995–1996
- Magnesium Repletion &Cyclobenzaprine In Eosinophilia Myalgia SyndromeNational Center For Research Resources1995–1996
- 2-Chlorodeoxyadenosine Infusion Therapy In Rheumatoid ArthritisNational Center For Research Resources1995–1996
- Tenidap Sodium And Piroxicam On Biochemical And Tissue Markers In RANational Center For Research Resources1995
- Safety And Efficacy Of Tolrestat In Limited Joint Mobility In DiabeticsNational Center For Research Resources1995
- Safety And Efficacy Of Delfazacort In Rheumatoid Arthritis, Pmr, DermatomyositisNational Center For Research Resources1995
- Phase II Study Of Chimeric Anti-Cd4 And Methotrexate In Rheumatoid ArthritisNational Center For Research Resources1995
- Rheumatoid Arthritis And Osteoporosis--Piroxicam To Suppress RA DiseaseNational Center For Research Resources1985
- Relationship Of Breast Augmentatin And Connective Tissue DiseaseNational Center For Research Resources1985
- Oral Chrysotherapeutic Of Systemic Lupus ErythematosusNational Center For Research Resources1985
- Efficacy Of Oral GOLD (AURANOFIN) In Treatment Of Rheumatoid ArthritisNational Center For Research Resources1985
- Double-Blind Comparison Of Injectable Versus Oral GOLDNational Center For Research Resources1985
- Dietary Management Of Rheumatoid ArthritisNational Center For Research Resources1985
- Calcium Pyrophosphate Dihydrate Deposition (CPPD) DiseaseNational Center For Research Resources1985
Professional Memberships
- Member
Hospital Affiliations
Cedars-Sinai Medical CenterLos Angeles, California
